Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, Sawcer SJ, Oksenberg JR, Hauser SL; IMAGEN; IMSGC. Cree BA, et al. PLoS One. 2010 Jun 25;5(6):e11296. doi: 10.1371/journal.pone.0011296. PLoS One. 2010. PMID: 20593013 Free PMC article.
Switching multiple sclerosis patients with breakthrough disease to second-line therapy.
Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. Castillo-Trivino T, et al. Among authors: cree ba. PLoS One. 2011 Feb 3;6(2):e16664. doi: 10.1371/journal.pone.0016664. PLoS One. 2011. PMID: 21304907 Free PMC article.
B cell exchange across the blood-brain barrier in multiple sclerosis.
von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL. von Büdingen HC, et al. Among authors: cree ba. J Clin Invest. 2012 Dec;122(12):4533-43. doi: 10.1172/JCI63842. Epub 2012 Nov 19. J Clin Invest. 2012. PMID: 23160197 Free PMC article.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D. Azevedo CJ, et al. Among authors: cree ba. Ann Neurol. 2014 Aug;76(2):269-78. doi: 10.1002/ana.24202. Epub 2014 Jul 9. Ann Neurol. 2014. PMID: 25043416 Free PMC article.
Diagnosing Encephalitis, Not Otherwise Specified-Reply.
Gelfand JM, Tihan T, Cree BA. Gelfand JM, et al. Among authors: cree ba. JAMA Neurol. 2015 Jun;72(6):726-7. doi: 10.1001/jamaneurol.2015.0548. JAMA Neurol. 2015. PMID: 26053447 No abstract available.
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. Green AJ, et al. Among authors: cree ba. Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10. Lancet. 2017. PMID: 29029896 Clinical Trial.
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial.
Laurent SA, Strauli NB, Eggers EL, Wu H, Michel B, Demuth S, Palanichamy A, Wilson MR, Sirota M, Hernandez RD, Cree BAC, Herman AE, von Büdingen HC. Laurent SA, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 24;10(4):e200118. doi: 10.1212/NXI.0000000000200118. Print 2023 Jul. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37094998 Free PMC article. Clinical Trial.
222 results